Curium’s 14 Million Patients to Benefit From Regular Supply of Mo-99 and Tc-99
PARIS, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Curium, the world’s leading nuclear medicine company, announced today that with the successful restarting of the BR2 research reactor in Belgium on 20 December, Curium’s supply of molybdenum-99…